1-[4-(2-oxo-2-phenylethyl)phenyl]guanidine

Identification

Generic Name
1-[4-(2-oxo-2-phenylethyl)phenyl]guanidine
DrugBank Accession Number
DB07122
Background

Not Available

Type
Small Molecule
Groups
Experimental
Structure
Weight
Average: 253.2991
Monoisotopic: 253.121512117
Chemical Formula
C15H15N3O
Synonyms
Not Available

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
TargetActionsOrganism
UUrokinase-type plasminogen activatorNot AvailableHumans
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Categories

Drug Categories
Not Available
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as stilbenes. These are organic compounds containing a 1,2-diphenylethylene moiety. Stilbenes (C6-C2-C6 ) are derived from the common phenylpropene (C6-C3) skeleton building block. The introduction of one or more hydroxyl groups to a phenyl ring lead to stilbenoids.
Kingdom
Organic compounds
Super Class
Phenylpropanoids and polyketides
Class
Stilbenes
Sub Class
Not Available
Direct Parent
Stilbenes
Alternative Parents
Alkyl-phenylketones / Benzoyl derivatives / Aryl alkyl ketones / Guanidines / Carboximidamides / Organopnictogen compounds / Organic oxides / Imines / Hydrocarbon derivatives
Substituents
Alkyl-phenylketone / Aromatic homomonocyclic compound / Aryl alkyl ketone / Aryl ketone / Benzenoid / Benzoyl / Carboximidamide / Guanidine / Hydrocarbon derivative / Imine
Molecular Framework
Aromatic homomonocyclic compounds
External Descriptors
Not Available
Affected organisms
Not Available

Chemical Identifiers

UNII
Not Available
CAS number
Not Available
InChI Key
MERNPSIIBFTCAI-UHFFFAOYSA-N
InChI
InChI=1S/C15H15N3O/c16-15(17)18-13-8-6-11(7-9-13)10-14(19)12-4-2-1-3-5-12/h1-9H,10H2,(H4,16,17,18)
IUPAC Name
N''-[4-(2-oxo-2-phenylethyl)phenyl]guanidine
SMILES
NC(N)=NC1=CC=C(CC(=O)C2=CC=CC=C2)C=C1

References

General References
Not Available
PubChem Compound
16758228
PubChem Substance
99443593
ChemSpider
22376304
ZINC
ZINC000016052491
PDBe Ligand
4PG
PDB Entries
2r2w

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility0.0346 mg/mLALOGPS
logP1.58ALOGPS
logP1.97Chemaxon
logS-3.9ALOGPS
pKa (Strongest Acidic)14.54Chemaxon
pKa (Strongest Basic)10.89Chemaxon
Physiological Charge1Chemaxon
Hydrogen Acceptor Count4Chemaxon
Hydrogen Donor Count2Chemaxon
Polar Surface Area81.47 Å2Chemaxon
Rotatable Bond Count4Chemaxon
Refractivity77.26 m3·mol-1Chemaxon
Polarizability27.29 Å3Chemaxon
Number of Rings2Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterYesChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
PropertyValueProbability
Human Intestinal Absorption+0.9474
Blood Brain Barrier+0.9266
Caco-2 permeable-0.5699
P-glycoprotein substrateNon-substrate0.6852
P-glycoprotein inhibitor INon-inhibitor0.8263
P-glycoprotein inhibitor IINon-inhibitor0.5956
Renal organic cation transporterNon-inhibitor0.6133
CYP450 2C9 substrateNon-substrate0.7859
CYP450 2D6 substrateNon-substrate0.7566
CYP450 3A4 substrateNon-substrate0.762
CYP450 1A2 substrateNon-inhibitor0.7103
CYP450 2C9 inhibitorNon-inhibitor0.8162
CYP450 2D6 inhibitorNon-inhibitor0.7208
CYP450 2C19 inhibitorNon-inhibitor0.7207
CYP450 3A4 inhibitorNon-inhibitor0.8444
CYP450 inhibitory promiscuityHigh CYP Inhibitory Promiscuity0.5692
Ames testAMES toxic0.5815
CarcinogenicityNon-carcinogens0.6287
BiodegradationNot ready biodegradable0.9678
Rat acute toxicity2.7310 LD50, mol/kg Not applicable
hERG inhibition (predictor I)Weak inhibitor0.8873
hERG inhibition (predictor II)Non-inhibitor0.9044
ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397)

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSsplash10-0a4i-6910000000-1c20cdec1ffff30ea334
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-0udi-0090000000-930abad6658a779b7098
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-03di-0090000000-cd9140cd0953e6ddaded
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-0ikc-3490000000-d93d073b60233333b3f6
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-0k9i-0490000000-51ba427d72fccb59b18c
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-0006-9300000000-6f6ebf0765a2b3ffa7c5
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-0a4i-3920000000-f266777748e5d15141b3
Predicted 1H NMR Spectrum1D NMRNot Applicable
Predicted 13C NMR Spectrum1D NMRNot Applicable
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-162.82234
predicted
DeepCCS 1.0 (2019)
[M+H]+165.18033
predicted
DeepCCS 1.0 (2019)
[M+Na]+171.27348
predicted
DeepCCS 1.0 (2019)

Targets

Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock new
insights and accelerate drug research.
Learn more
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
Learn more
Kind
Protein
Organism
Humans
Pharmacological action
Unknown
General Function
Serine-type endopeptidase activity
Specific Function
Specifically cleaves the zymogen plasminogen to form the active enzyme plasmin.
Gene Name
PLAU
Uniprot ID
P00749
Uniprot Name
Urokinase-type plasminogen activator
Molecular Weight
48507.09 Da
References
  1. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article]

Drug created at September 15, 2010 21:19 / Updated at June 12, 2020 16:52